Key result
Low-dose amiodarone at daily triggers fatal pulmonary toxicity.
Why the study?
Amiodarone pulmonary toxicity can be fatal and occurs even at low doses, posing a diagnostic challenge without specific clinical features.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Amiodarone-induced pulmonary toxicity can be fatal even at low maintenance doses (100 mg/day), highlighting the need for close monitoring in high-risk patients.
Introduction: Amiodarone pulmonary toxicity (APT) can be a diagnostic challenge to clinicians as it has no pathognomonic clinical, laboratory, radiological or histological features. It can potentially be fatal particularly in high risk patients. Amiodarone pulmonary toxicity is dose dependent however low dosages have also been reported to cause severe pulmonary disease. Therefore, it should be considered in every patient with respiratory distress and on current or recent amiodarone therapy. Case Report: We report a case of APT with fatal outcome in a 49-year-old lady taking the recommended doses of amiodarone with history of atrial fibrillation, rheumatic heart disease and pulmonary hypertension. Our patient was taking amiodarone for 3 years. She presented with severe respiratory distress necessitating endotracheal Intubation. Despite treatment with systemic corticosteroids and broad spectrum antimicrobials, patient died in hospital after one month of Intensive care unit (ICU) admission. Amiodarone pulmonary toxicity is usually dose-dependent however our patient was taking safe doses which make this case unique. Conclusion: The knowledge of different safe dosage patterns is important for every working physician due to widely usage of the drug. The lowest effective dose of amiodarone should be determined for every patient requiring long-term treatment and needs a close and regular follow-up for early diagnosis of lung injury.
No takes yet. Share an insight, caveat, or question.
Muhammad Imran Butt (2016) conducted a case report in Amiodarone-induced pulmonary toxicity (n=1). Amiodarone was evaluated on Fatal pulmonary toxicity. A 49-year-old female developed fatal amiodarone-induced pulmonary toxicity despite taking a low maintenance dose of per day for three years.
Synapse has enriched 10 related papers. Consider them for comparative context: